These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1042 related items for PubMed ID: 20935265
1. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV. J Natl Cancer Inst; 2010 Nov 03; 102(21):1637-52. PubMed ID: 20935265 [Abstract] [Full Text] [Related]
2. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R, Badve S, Srour EF, Nakshatri H. BMC Cancer; 2010 Aug 06; 10():411. PubMed ID: 20691079 [Abstract] [Full Text] [Related]
3. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y. BMC Cancer; 2010 Aug 10; 10():414. PubMed ID: 20696077 [Abstract] [Full Text] [Related]
4. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance. Tsou SH, Chen TM, Hsiao HT, Chen YH. PLoS One; 2015 Aug 10; 10(1):e0116747. PubMed ID: 25635866 [Abstract] [Full Text] [Related]
5. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE. PLoS One; 2011 Aug 10; 6(6):e20636. PubMed ID: 21695188 [Abstract] [Full Text] [Related]
6. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7. Fang XJ, Jiang H, Zhao XP, Jiang WM. BMC Cancer; 2011 Jul 12; 11():290. PubMed ID: 21749678 [Abstract] [Full Text] [Related]
7. Preliminary study of the effects of β-elemene on MCF-7/ADM breast cancer stem cells. Dong Y, Li L, Wang L, Zhou T, Liu JW, Gao YJ. Genet Mol Res; 2015 Mar 27; 14(1):2347-55. PubMed ID: 25867381 [Abstract] [Full Text] [Related]
8. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD. Yin BB, Wu SJ, Zong HJ, Ma BJ, Cai D. J Zhejiang Univ Sci B; 2011 Apr 27; 12(4):256-63. PubMed ID: 21462380 [Abstract] [Full Text] [Related]
9. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y. Oncol Rep; 2010 May 27; 23(5):1469-75. PubMed ID: 20372866 [Abstract] [Full Text] [Related]
10. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ, Wu CC, Li JW, Ou CC, Hsu SC, Tseng HH, Kao MC, Liu JY. Oncotarget; 2016 Nov 29; 7(48):78499-78515. PubMed ID: 27655682 [Abstract] [Full Text] [Related]
11. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties. Sun H, Jia J, Wang X, Ma B, Di L, Song G, Ren J. Clin Transl Oncol; 2013 Jan 29; 15(1):46-54. PubMed ID: 22855175 [Abstract] [Full Text] [Related]
12. [Effect of different heating methods combined with neferine on the expressions of γH2AX and mdr-1/P-gp in MCF-7/Adr breast cancer cells]. Huang C, Cao P, Xie Z, Zhu H. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Apr 29; 36(4):317-22. PubMed ID: 21566283 [Abstract] [Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J, Fang X, Hao J, Sha X. Biomaterials; 2015 Mar 29; 45():99-114. PubMed ID: 25662500 [Abstract] [Full Text] [Related]
14. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlöw B, Nestor M. PLoS One; 2014 Mar 29; 9(4):e94621. PubMed ID: 24760019 [Abstract] [Full Text] [Related]
15. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W. Int J Cancer; 2012 Jan 01; 130(1):29-39. PubMed ID: 21480217 [Abstract] [Full Text] [Related]
16. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL. Br J Cancer; 2008 Feb 26; 98(4):756-65. PubMed ID: 18268494 [Abstract] [Full Text] [Related]
17. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1. Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, Ali S, Li Y, Kong D, Banerjee S, Back J, Sarkar FH. J Biol Chem; 2014 May 23; 289(21):14520-33. PubMed ID: 24719318 [Abstract] [Full Text] [Related]
18. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G. Proc Natl Acad Sci U S A; 2009 Sep 22; 106(38):16281-6. PubMed ID: 19805294 [Abstract] [Full Text] [Related]
19. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Muraro MG, Mele V, Däster S, Han J, Heberer M, Cesare Spagnoli G, Iezzi G. Stem Cells Transl Med; 2012 Aug 22; 1(8):592-603. PubMed ID: 23197865 [Abstract] [Full Text] [Related]
20. Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms. Wu M, Li T, Chen L, Peng S, Liao W, Bai R, Zhao X, Yang H, Wu C, Zeng H, Liu Y. J Ethnopharmacol; 2016 Mar 02; 180():18-27. PubMed ID: 26795076 [Abstract] [Full Text] [Related] Page: [Next] [New Search]